Article
Early Improvement of Affective, Fatigue and Allodynic Symptoms in a Cohort of Resistant Migraineurs Treated with Anti-CGRP/R Antibodies
2024-02-02
Abstract excerpt
<h4>Objective: </h4> The study aimed to evaluate the effects of monoclonal antibodies (mAbs) acting on the calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRP/R mAbs) on comorbid symptoms of depression, anxiety, and fatigue in migraine patients resistant to traditional prophylaxis. <h4>Methods:</h4> The study was an open-label prospective study assessing comorbidities in patients with high frequency...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2c4a426-74f1-55b2-97a9-f5f82e1c60ec
- DOI
- 10.20944/preprints202402.0108.v1
